Hong kong study tracks severe asthma patients to improve care
NCT ID NCT04639791
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 500 adults in Hong Kong with severe asthma who are on high-dose treatments (step 4 or 5 of GINA guidelines). Researchers will track how well their asthma is controlled and how often they have flare-ups over two years. The goal is to gather local data to help doctors manage severe asthma and use expensive biologic drugs more wisely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide local data to help doctors better manage severe asthma and use biologic treatments more effectively.
- What could go wrong
- This is an observational study, not testing a new treatment, so it won't directly improve outcomes. Results may not apply outside Hong Kong.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prince of Wales Hospital
RECRUITINGShatin, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking severe asthma over time unlock better treatments?
- Can pressurized breathing boost mucus clearance in lung disease?
- Can a simple breathing test unlock the secrets of chronic cough?
- Can a Breath-Activated inhaler match the standard for asthma control?
- Can a School-Home program tame childhood asthma?
- Could everyday supplements shield your lungs?